RESECTABLE PANCREATIC CANCER
Clinical trials for RESECTABLE PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for RESECTABLE PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for pancreatic cancer patients: drug combo trial before surgery
Disease control OngoingThis early-stage study is testing whether adding the drug ivosidenib to standard chemotherapy (mFOLFIRINOX) before surgery helps people with operable pancreatic cancer. The goal is to see if this combination is safe and effective at shrinking tumors before surgical removal. Resea…
Matched conditions: RESECTABLE PANCREATIC CANCER
Phase: PHASE1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Canadian researchers hunt for a better way to personalize pancreatic cancer treatment
Knowledge-focused OngoingThis study aims to learn if measuring a specific protein (GATA6) in a patient's tumor can help doctors predict who will benefit most from a specific chemotherapy regimen given before and after surgery for pancreatic cancer. It involves 84 patients across Canada with early-stage, …
Matched conditions: RESECTABLE PANCREATIC CANCER
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC